Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982;8(2):221-9.
doi: 10.1007/BF00255488.

Renal handling of 2'-deoxyadenosine and adenosine in humans and mice

Renal handling of 2'-deoxyadenosine and adenosine in humans and mice

J F Kuttesch Jr et al. Cancer Chemother Pharmacol. 1982.

Abstract

In a child lacking adenosine deaminase and in patients treated with deoxycoformycin (a potent inhibitor of the enzyme), apparent renal secretion of 2'-deoxyadenosine (dAdo) and reabsorption of adenosine (Ado) were observed. The renal clearance of dAdo in humans was approximately five-fold that of creatinine, whereas the renal clearance of Ado was only one-fifth that of creatinine. In mice treated with deoxycoformycin, a similar paradigm was observed. Specifically, plasma levels of Ado and dAdo were elevated to detectable levels and apparent renal secretion and reabsorption of these purine nucleosides became manifest. Thus, the mouse may serve as a suitable model to study the renal handling of these two compounds. The active renal secretion of dAdo may occur because the compound has not been appreciably synthesized by mouse kidney in situ, and 'ion-trapping' of dAdo in acid urine could not explain the net secretion. The differential transport of these similar purine nucleosides suggests a very selective transport system in mammalian kidney. Although carrier-mediated, facilitated diffusion of purine nucleosides across cell membranes is a well-known ph enomenon, the present data indicate the existence of (an) active transport system(s) for the transepithelial secretion of dAdo, and possibly for the reabsorption of Ado.

PubMed Disclaimer

References

    1. Clin Sci Mol Med. 1978 May;54(5):579-84 - PubMed
    1. J Chromatogr. 1976 Nov 3;126:679-91 - PubMed
    1. Biochem Med. 1978 Oct;20(2):180-99 - PubMed
    1. Proc Natl Acad Sci U S A. 1976 Aug;73(8):2867-71 - PubMed
    1. Proc Soc Exp Biol Med. 1970 Nov;135(2):320-4 - PubMed

Publication types

MeSH terms

LinkOut - more resources